"Mexico Pharmaceuticals & Healthcare Report Q4 2013" Is Now Available at Fast Market Research
Under the Pacific Alliance agreement, Chile, Peru and Colombia will recognise medicine registrations issued by COFEPRlS and allow easy entry to pharmaceutical products approved by the organisation. Mexico's well-recognised drug approval standard among Latin American countries should encourage multinationals to launch more products in the country and pave the way for an integrated pharmaceutical market among Pacific Alliance member states. Multinationals and Mexican drugmakers will enjoy faster access to markets in the member states, and local consumers will immediately have...
View full press release